Skip to main content

Table 3 Correlation between status of surgical resection and tumor progression/death

From: Preoperative imatinib mesylate (IM) for huge gastrointestinal stromal tumors (GIST)

Variables

Progression

n (%)

Death

n (%)

Overall (n = 28)

4 (14.3)

2 (7.1)

 Surgery (n = 19)

2 (10.5)

0 (0)

 No surgery (n = 9)

2 (22.2)

2 (22.2)

Primary (n = 16)

1 (6.3)

0 (0)

 Surgery (n = 13)

1 (7.7)

0 (0)

 No Surgery (n = 3)

0 (0)

0 (0)

Recurrent/metastatic (n = 12)

3 (25.0)

2 (16.7)

 Surgery (n = 6)

1 (16.7)

0 (0)

 No Surgery (n = 6)

2 (33.3)

2 (33.3)